COVID-19-Associated Thromboembolism
Conditions
Keywords
COVID-19, thromboembolism, Variants of COVID-19
Brief summary
The present study aims to determine frequency of thromboembolic complications and the underlying causes of this complication of the patients who admitted to the intensive care unit diagnosed with COVID-19.
Detailed description
Patients diagnosed with COVID-19 infection and admitted to the ICU were recruited. Demographic information, comorbidities, length of ICU stay, some laboratory data,thromboembolic complications of the patients were recorded.
Interventions
None listed
Sponsors
Ayse Zeynep Turan
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients who were infected with COVID-19 and admitted to the intensive care unit between the time of March 2020-December 2021
Exclusion criteria
* who is under 18 years old.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease | During the entire intensive care stay up to 1 day | Both arterial and venous thromboembolic events were detected |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of thromboembolic complications of COVID-19 disease in critically ill patients | During the entire intensive care stay up to 1 day | Both arterial and venous thromboembolic events were detected |
| Rate of thromboembolic complications according to anticoagulant therapy | During the entire intensive care stay up to 1 day | Antithrombotic therapy of each patient was recorded |
| What is the rate of thromboembolism according to the comorbidities | During the entire intensive care stay up to 1 day | Comorbidities of each patient were recorded from the patients records. |
Countries
Turkey (Türkiye)
Outcome results
None listed